Purpose

Investigators want to find better ways for doctors and families to talk about cancer and how uncertainty may affect a child's life.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All participants must be ≥ 18 years of age or legally emancipated - Parent Participants must have a child who: - Received cancer care from a clinician at St. Jude, as documented in the electronic medical record, AND - Died at least 6 months prior to enrollment, but no more than 24 months prior to enrollment. - Oncologist participants at St. Jude must: - Be listed as the primary oncologist as documented in the electronic medical record, AND - Have the respective patient's parent agreement to participate in the study.

Exclusion Criteria

  • Declining, refusal, or unwillingness to participate - Inability or unwillingness of research participant to give informed consent.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Parent Participants Parents who have lost a child to cancer
Oncologist Participants St. Jude doctors who treated the child

Recruiting Locations

St. Jude Children's Research Hospital
Memphis, Tennessee 38105
Contact:
Stephanie Gehle, MD
888-226-4343
referralinfo@stjude.org

More Details

Status
Recruiting
Sponsor
St. Jude Children's Research Hospital

Study Contact

Stephanie Gehle, MD
888-226-4343
referralinfo@stjude.org

Detailed Description

Primary Objective - To characterize how bereaved parents of children with cancer and their child's oncologist perceive their experience with communication about prognostic uncertainty during the child's cancer journey and during bereavement. Secondary Objective - To elicit parents' and oncologists' preferences and recommendations for how clinicians should talk with children and families about prognosis in the setting of uncertainty. This study aims to explore bereaved parents' and oncologists' reflections on communication about prognostic uncertainty during the child's cancer treatment. Parents who have lost a child to cancer and the doctors who treated them will be invited to join this study. Participants who opt to participate in the study will engage in an audio recorded semi-structured interview with a researcher, virtually or in person (at their discretion) to share their perspectives and recommendations based on their experience. Throughout the interview, the interviewer has the option to ask additional questions (i.e., probe with questions not in the interview guide) to respond to comments made by the participant and honor the topics of interest to that given participant. The participant will be provided an opportunity to add any details or comments at the end of the interview if he/she would like to share additional information. Following completion of the qualitative portion of the interview, the researcher will ask the participant several questions from a demographic form. The demographic form will include questions related to participant age, race/ethnicity, state/country of residence for bereaved parents, and years of clinical practice for oncologists.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.